Evaluation of TTK Chitra heart valve prosthesis in pediatric patients

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiology
• Biomedical Engineering

Background:

• Mechanical heart valve replacement is a critical intervention for pediatric patients with severe valve disease.
• The TTK Chitra mechanical valve is a specific device used in cardiac procedures.
• Assessing the long-term outcomes of mechanical valves in pediatric populations is essential for clinical decision-making.

Purpose of the Study:

• To evaluate the clinical outcomes of pediatric patients undergoing valve replacement with the TTK Chitra mechanical valve.
• To assess survival rates and freedom from adverse events in this specific patient subgroup.
• To determine the long-term efficacy and safety of the TTK Chitra valve in pediatric cardiac surgery.

Main Methods:

• A prospective follow-up study of 27 pediatric patients who received TTK Chitra mechanical valve implantation between January 2006 and December 2018.
• The cohort included patients undergoing aortic valve replacement (AVR), mitral valve replacement (MVR), and double valve replacement (DVR).
• Total follow-up duration was 254 patient-years, with 90% completeness.

Main Results:

• The study demonstrated satisfactory survival rates and event-free rates among the pediatric patients.
• Specific follow-up data included 107 patient-years for AVR, 136 for MVR, and 11 for DVR.
• Despite initial concerns regarding high-risk procedures, the results indicate positive long-term performance.

Conclusions:

• The TTK Chitra mechanical valve replacement offers acceptable long-term survival in pediatric patients.
• The long-term benefits of utilizing a durable mechanical valve appear to outweigh the inherent risks in this population.
• This study supports the consideration of the TTK Chitra valve for pediatric heart valve replacement when indicated.